Patents by Inventor Samuel P. Sawan

Samuel P. Sawan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210349064
    Abstract: The present invention provides derivatized indicator compounds, such as pH indicator compounds, which can be covalently immobilized to a variety of solid substrates to produce an indicator pad. Such pads can be used to monitor water quality in variety of settings. In particular, the pads of the invention are useful in devices which monitor the quality of recreational water, such as water in swimming pools, hot tubs, and amusement park attractions, including water slides, and water-based rides. The present invention overcomes the limitations of commercially available pad chemistries.
    Type: Application
    Filed: May 21, 2021
    Publication date: November 11, 2021
    Inventors: Samuel P. Sawan, Alexander V. Yurkovetskiy
  • Publication number: 20200323834
    Abstract: The invention provides hydrohphobic drug salts and pharmaceutical compositions comprising such salts. The invention fourther provides compositions for delivering poorly soluble drugs, including hydrophobic drug salts.
    Type: Application
    Filed: April 28, 2020
    Publication date: October 15, 2020
    Inventor: Samuel P. Sawan
  • Publication number: 20200323833
    Abstract: The invention provides acid addition salts of a basic therapeutic agent wherein the acid is represented by Formula I, R—X??(I), wherein R is a haloalkyl group and X is —SO3H, C(O)OH or P(O)(OR1)(OH), where R1 is hydrogen or C1-C6-alkyl. The invention also provides pharmaceutical compositions comprising a pharmaceutically acceptable carrier or excipient and an acid addition salt of the invention and a method of using an acid addition salt of the invention for treating a disease or disorder in a subject in need thereof.
    Type: Application
    Filed: April 28, 2020
    Publication date: October 15, 2020
    Inventor: Samuel P. Sawan
  • Publication number: 20200323986
    Abstract: The invention provides acid addition salts of a basic therapeutic agent wherein the acid is represented by Formula I or Formula II, wherein Ar, R1, R2, R3, R4, and R5 are as defined herein. The invention also provides pharmaceutical compositions comprising a pharmaceutically acceptable carrier or excipient and an acid addition salt of the invention and a method of using an acid addition salt of the invention for treating a disease or disorder in a subject in need thereof.
    Type: Application
    Filed: April 28, 2020
    Publication date: October 15, 2020
    Inventor: Samuel P. Sawan
  • Publication number: 20200323990
    Abstract: The present invention provides a salt of an acidic drug and a hydrophobic cation, pharmaceutical compositions comprising such salts and methods of using such salts to treat or prevent a disease or disorder.
    Type: Application
    Filed: April 28, 2020
    Publication date: October 15, 2020
    Inventor: Samuel P. Sawan
  • Patent number: 8920843
    Abstract: Particles of an organic acid salt of an amino acid amide or ester local anesthetic are employed as agents for the improved alleviation of pain. Particularly, the particles find use with surgically created wounds, where the particles may be administered directly into the bed of the wound or topically for transdermal transport.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: December 30, 2014
    Assignee: SVIP5 LLC
    Inventors: Samuel P. Sawan, Daniel Jacobs, Tadmor Shalon
  • Publication number: 20110184057
    Abstract: Cancer patients, patients with cognitive dysfunction, or patients with pulmonary hypertension are treated with parenterally administered therapeutic doses of statins. Particularly, transdermal, injection employing liquid infusion or particles are employed. For cancer, the statins may be used by themselves or in conjunction with a chemotherapeutic regimen. Liver cancer is treated orally with super doses of statins.
    Type: Application
    Filed: January 26, 2011
    Publication date: July 28, 2011
    Inventors: Gregory R. Mundy, Helen Mundy, Tadmor Shalon, Samuel P. Sawan
  • Publication number: 20100233271
    Abstract: Particles of an organic acid salt of an amino acid amide or ester local anesthetic are employed as agents for the improved alleviation of pain. Particularly, the particles find use with surgically created wounds, where the particles may be administered directly into the bed of the wound or topically for transdermal transport.
    Type: Application
    Filed: November 7, 2008
    Publication date: September 16, 2010
    Inventors: Samuel P. Sawan, Daniel Jacobs, Tadmor Shalon
  • Publication number: 20090181098
    Abstract: Methods of enhancing skeletal framework tissue are provided by treating a site requiring enhancement with an HMG-CoA reductase inhibitor at a dosage and for a duration that enhances the tissue while avoiding excess of the inhibitor and degradation of the enhancement.
    Type: Application
    Filed: March 6, 2007
    Publication date: July 16, 2009
    Applicant: OsteoScreen IP, LLC
    Inventors: Ian R Garrett, Gloria Gutierrez, Gianni Rossini, Samuel P. Sawan, Gregory R. Mundy
  • Patent number: 7288264
    Abstract: Contact killing antimicrobial articles, devices and formulations are described which kill microorganisms on contact. The articles, devices or formulations contain a non-leaching antimicrobial material which is a unique combination of an organic matrix having biocidal metallic materials non-leachably associated with the matrix. The antimicrobial material may used to form an antimicrobial coating or layer on a surface of the article or device, or may be dispersed in a vehicle or carrier to form a topical antiseptic or disinfectant, or solid shape having contact killing antimicrobial properties. When a microorganism contacts the article, device, or formulation, the biocidal metallic material is transferred to the microorganism in amounts sufficient to kill it.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: October 30, 2007
    Assignee: Surfacine Development Company, L.L.C.
    Inventors: Samuel P. Sawan, Tadmor Shalon, Sundar Subramanyam, Alexander Yurkovetskiy
  • Publication number: 20030165905
    Abstract: Methods are provide for modifying a solid support, such as a glass slide, by silylating with an agent having the formula H2N—(CH2)n—SiX3 where n is between 1 and 10, and X is independently chosen from OMe, OEt, Cl, Br, or I, then activating with a crosslinking reagent, followed by reacting with an amine-containing polymer. The support can optionally be reacted with a crosslinking reagent again. The support thus modified may be used to make arrays and microarrays where a plurality of targets are stably associated with the support and arranged in a defined manner.
    Type: Application
    Filed: July 1, 2002
    Publication date: September 4, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Lyle J. Arnold, Samuel P. Sawan, Paul H. Lee
  • Publication number: 20030147925
    Abstract: The present invention relates to a topical antimicrobial composition containing an antimicrobial complex that provides sustained antimicrobial disinfecting action upon contact with microorganisms for prolonged periods, without the necessity for reapplication. The topical antimicrobial composition provides both initial and residual contact-killing disinfecting activity, and does not release its antimicrobial components into contacting liquids at levels that result in solution disinfection.
    Type: Application
    Filed: September 9, 1999
    Publication date: August 7, 2003
    Inventors: SAMUEL P. SAWAN, SUNDAR SUBRAMANYAM, ALEXANDER V. YURKOVETSKIY, GURUSAMY MANIVANNAN, MICHAEL GOLDBLATT
  • Patent number: 6413722
    Abstract: Methods are provide for modifying a solid support, such as a glass slide, by silylating with an agent having the formula H2N—(CH2)n—SiX3 where n is between 1 and 10, and X is independently chosen from OMe, OEt, Cl, Br, or I, then activating with a crosslinking reagent, followed by reacting with an amine-containing polymer. The support can optionally be reacted with a crosslinking reagent again. The support thus modified may be used to make arrays and microarrays where a plurality of targets are stably associated with the support and arranged in a defined manner.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: July 2, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Lyle J. Arnold, Samuel P. Sawan, Paul H. Lee
  • Patent number: 6387631
    Abstract: Methods are provide for modifying a solid support, such as a glass slide, by silylating with an agent having the formula H2N—(CH2)n—SiX3 where n is between 1 and 10, and X is independently chosen from OMe, OEt, Cl, Br, or I, then activating with a crosslinking reagent, followed by reacting with an amine-containing polymer. The support can optionally be reacted with a crosslinking reagent again. The support thus modified may be used to make arrays and microarrays where a plurality of targets are stably associated with the support and arranged in a defined manner.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: May 14, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Lyle J. Arnold, Samuel P. Sawan, Paul H. Lee
  • Publication number: 20020037509
    Abstract: Methods are provide for modifying a solid support, such as a glass slide, by silylating with an agent having the formula H2N-(CH2)n-SiX3 where n is between 1 and 10, and X is independently chosen from OMe, OEt, Cl, Br, or I, then activating with a crosslinking reagent, followed by reacting with an amine-containing polymer. The support can optionally be reacted with a crosslinking reagent again. The support thus modified may be used to make arrays and microarrays where a plurality of targets are stably associated with the support and arranged in a defined manner.
    Type: Application
    Filed: February 1, 2001
    Publication date: March 28, 2002
    Inventors: Lyle J. Arnold, Samuel P. Sawan, Paul H. Lee
  • Patent number: 6264936
    Abstract: An antimicrobial material is described which can be used to form on the surface on a substrate a non-leaching antimicrobial coating or layer which kills microorganisms on contact. The non-leaching antimicrobial coating or layer is a unique combination of an organic matrix immobilized on the surface of the substrate to having biocidal metallic materials non-leachably associated with the matrix. When a microorganism contacts the coating or layer, the biocidal metallic material is transferred to the microorganism in amounts sufficient to kill it. Methods of applying the coating or layer to a substrate also are provided.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: July 24, 2001
    Assignees: BioPolymerix, Inc., Surfacine Development Company, LLC
    Inventors: Samuel P. Sawan, Sundar Subramanyam, Alexander Yurkovetskiy
  • Patent number: 6180584
    Abstract: The present invention relates to a composition that, when applied to a substrate, forms an adherent, transparent, water insoluble polymeric film on the substrate surface that provides sustained antimicrobial disinfecting action for prolonged periods, without the necessity for reapplication. The coating provides surface disinfecting action by a contact-killing mechanism, and does not release its components into contacting solutions at levels that would result in solution disinfection. The polymeric film formed by the composition of the invention can be removed by treatment with dilute alcoholic base.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: January 30, 2001
    Assignee: Surfacine Development Company, LLC
    Inventors: Samuel P. Sawan, Sundar Subramanyam, Alexander Yurkovetskiy
  • Patent number: 6126931
    Abstract: Contact killing antimicrobial articles, devices and formulations are described which kill microorganisms on contact. The articles, devices or formulations contain a non-leaching antimicrobial material which is a unique combination of an organic matrix having biocidal metallic materials non-leachably associated with the matrix. The antimicrobial material may used to form an antimicrobial coating or layer on a surface of the article or device, or may be dispersed in a vehicle or carrier to form a topical antiseptic or disinfectant, or solid shape having contact killing antimicrobial properties. When a microorganism contacts the article, device, or formulation, the biocidal metallic material is transferred to the microorganism in amounts sufficient to kill it.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: October 3, 2000
    Assignees: Surfacine Development Company, LLC, BioPolymerix, Inc.
    Inventors: Samuel P. Sawan, Sundar Subramanyam, Alexander Yurkovetskiy
  • Patent number: 6030632
    Abstract: An antimicrobial material comprising an antimicrobial metallic material and a biguanide polymer reacted with a crosslinker to form an adduct is described. Both freestanding antimicrobial materials and antimicrobial films are provided. The antimicrobial material does not release biocidal levels of leachables into a contacting solution.
    Type: Grant
    Filed: September 11, 1998
    Date of Patent: February 29, 2000
    Assignee: BioPolymerix and Surfacine Development Company
    Inventors: Samuel P. Sawan, Sundar Subramanyam, Alexander Yurkovetskiy
  • Patent number: RE46397
    Abstract: Particles of an organic acid salt of an amino acid amide or ester local anesthetic are employed as agents for the improved alleviation of pain. Particularly, the particles find use with surgically created wounds, where the particles may be administered directly into the bed of the wound or topically for transdermal transport.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: May 9, 2017
    Assignee: SVIP5 LLC
    Inventors: Samuel P. Sawan, Daniel Jacobs, Tadmor Shalon